{"id":"NCT01855919","sponsor":"Eli Lilly and Company","briefTitle":"A Study of Duloxetine (LY248686) in Participants With Chronic Low Back Pain","officialTitle":"Effect of Duloxetine 60 mg Versus Placebo in Patients With Chronic Low Back Pain in Japan","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-05","primaryCompletion":"2014-07","completion":"2014-07","firstPosted":"2013-05-17","resultsPosted":"2015-07-23","lastUpdate":"2015-07-23"},"enrollment":458,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Back Pain Lower Back Chronic"],"interventions":[{"type":"DRUG","name":"Duloxetine","otherNames":["Cymbalta","LY248686"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Duloxetine","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of the study is to assess the efficacy and safety of duloxetine in participants with Chronic Low Back Pain (CLBP).","primaryOutcome":{"measure":"Change From Baseline to Week 14 in Brief Pain Inventory (BPI) 24-Hour Average Pain Severity Item","timeFrame":"Baseline, Week 14","effectByArm":[{"arm":"Duloxetine","deltaMin":-2.43,"sd":0.11},{"arm":"Placebo","deltaMin":-1.96,"sd":0.11}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0026"}]},"eligibility":{"minAge":"20 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":24},"locations":{"siteCount":1,"countries":["Japan"]},"refs":{"pmids":["31875196","28919811"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":4,"n":234},"commonTop":["Nasopharyngitis","Somnolence","Constipation","Nausea","Contusion"]}}